News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 1281
- Sources here
- 18
- Companies here
- 27
Search results
Stored financial headlines
Active search
1281 matching headlines
Ticker or company: BBMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
QRG Capital Management Inc. Lowers Holdings in Abbott Laboratories $ABT
QRG Capital Management Inc. reduced its stake in Abbott Laboratories (NYSE:ABT) by 28.7% in the second quarter, selling 83,416 shares and retaining 207,173 shares worth approximately $18.8 million. Despite this reduction, institutional investors collectively own 75.18% of ABT. Abbott Laboratories recently reported stronger-than-expected quarterly …
ABT
main company
Sharemaestro market context
Price above Trend Line
52 weeks -14.8% · Next-week setup positive 55.5%
Abbott Laboratories Revenue Breakdown – AQUISUK:ABLD
This article provides a revenue breakdown for Abbott Laboratories (ABLD) on the Aquis Stock Exchange. It highlights that in the last year, the company generated 37.74 billion EUR, with Medical Devices being the top-performing segment at 18.21 billion EUR. The United States was the …
ABT
main company
Sharemaestro market context
Price above Trend Line
52 weeks -14.8% · Next-week setup positive 55.5%
Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval Lands
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Bristol-Myers Squibb stock has delivered a 38.1% gain over the past year, while valuation …
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1%BBB Foods Inc (TBBB) (Q2 2026) Earnings Call Highlights: Revenue Surges 39% and Same-Store ...
This article first appeared on GuruFocus. Total Revenue: MXN 26 billion, up 39% year-over-year. Same-Store Sales: Increased 20% compared to the second quarter of 2025. EBITDA (Reported): MXN 960 million. EBITDA (Excluding Non-Cash Share-Based Compensation): Increased 44% to MXN 1.6 billion. Adjusted EBITDA Margin: …
Sharemaestro market context Trend signal active 52 weeks +69.6%Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health?
On August 11, medtech leader Abbott Laboratories (NYSE:ABT) and tech behemoth Alphabet Inc. (NASDAQ:GOOG) announced a multi-year partnership to unite continuous glucose monitoring with consumer AI. The collaboration embeds data from Abbott's non-prescription Lingo biowearable directly into the Google Health app, combining real-time metabolic …
Sharemaestro market context Price above Trend Line 52 weeks -1.0% · Next-week setup positive 57.3%2 Reasons to Like ABBV and 1 to Stay Skeptical
2 Reasons to Like ABBV and 1 to Stay Skeptical AbbVie has followed the market's trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.7% to $249.64 per share while the index has gained …
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8%Blackberry Stock Price Forecast. Should You Buy BB?
StockInvest.us rates BlackBerry Limited (BB) as a Sell Candidate with a technical score of -1.56, unchanged from its previous evaluation. Despite a 5.70% price increase since a sell signal on July 27, 2026, and a predicted 6.96% rise over the next three months, the …
BB
main company
Sharemaestro market context
Trend signal active
52 weeks +136.7%
Royal Caribbean Group stock underperforms Friday when compared to competitors
Royal Caribbean Group (RCL) stock fell by 1.57% on Friday, closing at $305.00, despite a two-day winning streak. This underperformance occurred on a generally negative trading day for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also declining. …
RCL
main company
Sharemaestro market context
Trend signal active
52 weeks -10.0%
Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma
Bristol Myers Squibb's drug, iberdomide (Zenbexus), has received accelerated FDA approval for treating multiple myeloma, making it the first FDA-approved cereblon-modulating (CELMoD) protein degrader. Zenbexus is indicated for use with Darzalex Faspro and dexamethasone in adults who have received at least one prior line …
BMY
main company
Sharemaestro market context
Trend signal active
52 weeks +38.1%
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Bristol Myers Squibb (BMY) is back in focus after the FDA granted accelerated approval for ZENBEXUS in a multiple myeloma combination regimen, introducing …
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1%American Century entities (GT) disclose 5%+ beneficial ownership in Goodyear stock
American Century entities, including American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research, have disclosed beneficial ownership of over 5% of Goodyear Tire & Rubber Company common stock. The American Century ETF Trust …
GT
main company
Sharemaestro market context
Price below Trend Line
52 weeks -29.4%
Can ABBV's Neuroscience Drugs Drive Growth in the Second Half of 2026?
AbbVie's neuroscience franchise experienced strong growth in the first half of 2026, with sales reaching $6.1 billion, driven by key drugs like Vraylar, Ubrelvy, Qulipta, and Botox Therapeutic, and the rapid uptake of Vyalev. The company anticipates further growth from the potential approval of …
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8%BBB Foods (TBBB): Quilvest group reports 3.5% beneficial stake via Class C shares
The Quilvest group, through various investment entities, has reported a 3.5% beneficial ownership stake in BBB Foods Inc. (TBBB) via Class C Common Shares. As of June 30, 2026, the group held 2,299,502 Class C shares, which are treated as convertible into Class A …
TBBB
main company
Sharemaestro market context
Trend signal active
52 weeks +84.9%
The Bull Case For Royal Caribbean Cruises (RCL) Could Change Following New 2034 Bond Sale And Profit Upgrade
Royal Caribbean Cruises (RCL) recently issued US$1.25 billion in 2034 senior unsecured notes shortly after raising its full-year profit outlook due to strong demand. This move indicates the company's willingness to use debt markets to fund growth, reinforcing the importance of sustained cruising appeal …
RCL
main company
Sharemaestro market context
Trend signal active
52 weeks -10.0%
Ribbon Communications to attend major tech and semiconductor conferences in August 2026
Ribbon Communications announced its participation in two major industry events in August 2026: the Rosenblatt 6th Annual Tech Summit on AI and the Jefferies Semiconductor, IT Hardware & Communications Technology Conference. The company aims to highlight its advancements in autonomous networks, leveraging AI and …
RBBN
main company
Sharemaestro market context
Price below Trend Line
52 weeks -46.9%
TBBB Crosses Above Average Analyst Target
In recent trading, shares of BBB Foods Inc (Symbol: TBBB) have crossed above the average analyst 12-month target price of $43.80, changing hands for $49.20/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade …
Sharemaestro market context Trend signal active 52 weeks +69.6%